Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thrombosis × reviparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Neoplasms 1

Interventions

Dalteparin 11 apixaban 8 Enoxaparin 7 edoxaban 5 Tinzaparin 5 Rivaroxaban 5 Heparin, Low-Molecular-Weight 4 Fondaparinux 3 Dabigatran 3 bemiparin 2 abelacimab 2 Warfarin 2 Nadroparin 2 MAA868 2 Heparin 2 reviparin 1 certoparin 1 calcium heparin 1 atezolizumab 1 acarboxyprothrombin 1 Ultrasonography, Doppler, Duplex 1 Rosuvastatin Calcium 1 Phenprocoumon 1 Laparoscopy 1 Intermittent Pneumatic Compression Devices 1 Imaging, Three-Dimensional 1 Hospitals 1 Fluorodeoxyglucose F18 1 Educational Status 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡